Viswanathan Muthusamy

1.8k total citations
28 papers, 1.4k citations indexed

About

Viswanathan Muthusamy is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Viswanathan Muthusamy has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Viswanathan Muthusamy's work include Epigenetics and DNA Methylation (7 papers), Cancer Genomics and Diagnostics (4 papers) and Cancer Cells and Metastasis (3 papers). Viswanathan Muthusamy is often cited by papers focused on Epigenetics and DNA Methylation (7 papers), Cancer Genomics and Diagnostics (4 papers) and Cancer Cells and Metastasis (3 papers). Viswanathan Muthusamy collaborates with scholars based in United States, India and Portugal. Viswanathan Muthusamy's co-authors include Marcus Bosenberg, G. Shanmugam, Nobuo Tsuchida, David P. Curley, Cara Hobbs, Betsy Nelson, Marcus Bosenberg, Cristina Nogueira, Lynda Chin and David A. Spiegel and has published in prestigious journals such as Angewandte Chemie International Edition, The Journal of Experimental Medicine and Cancer Cell.

In The Last Decade

Viswanathan Muthusamy

27 papers receiving 1.3k citations

Peers

Viswanathan Muthusamy

ONCOL

IMMUN

Shilpee Dutt India

Jenny G. Parvani United States

Hector Biliran United States

Francesca Di Modugno Italy

Jianhai Jiang China

Caining Jin United States

Dirk Wienke United Kingdom

Christine Gjerdrum Norway

Michaela Herzig Austria

Ahamed Saleem United States

Shilpee Dutt India

Viswanathan Muthusamy

902 ×0.9

295 ×0.6

ONCOL

269 ×1.0

IMMUN

199 ×1.0

138 ×0.9

Citations per year, relative to Viswanathan Muthusamy Viswanathan Muthusamy (= 1×) peers Shilpee Dutt

Countries citing papers authored by Viswanathan Muthusamy

Since Specialization

Citations

This map shows the geographic impact of Viswanathan Muthusamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viswanathan Muthusamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viswanathan Muthusamy more than expected).

Fields of papers citing papers by Viswanathan Muthusamy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viswanathan Muthusamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viswanathan Muthusamy. The network helps show where Viswanathan Muthusamy may publish in the future.

Co-authorship network of co-authors of Viswanathan Muthusamy

This figure shows the co-authorship network connecting the top 25 collaborators of Viswanathan Muthusamy. A scholar is included among the top collaborators of Viswanathan Muthusamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viswanathan Muthusamy. Viswanathan Muthusamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Krykbaeva, Irina, William Damsky, Meaghan K. McGeary, et al.. (2023). Combinatorial Immunotherapy with Agonistic CD40 Activates Dendritic Cells to Express IL12 and Overcomes PD-1 Resistance. Cancer Immunology Research. 11(10). 1332–1350. 12 indexed citations

Muthusamy, Viswanathan, et al.. (2023). Tackling FGFR3-driven bladder cancer with a promising synergistic FGFR/HDAC targeted therapy. npj Precision Oncology. 7(1). 70–70. 5 indexed citations

Muthusamy, Viswanathan, et al.. (2021). Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer Phenotypes. Cancer Research. 81(16). 4346–4359. 41 indexed citations

Zhang, Mengwen, Jason D. Ray, Venkata R. Sabbasani, et al.. (2021). Bifunctional small molecules that mediate the degradation of extracellular proteins. Nature Chemical Biology. 17(9). 947–953. 157 indexed citations

Newton, Ana S., John C. Faver, Goran Micevic, et al.. (2020). Structure-Guided Identification of DNMT3B Inhibitors. ACS Medicinal Chemistry Letters. 11(5). 971–976. 17 indexed citations

Muthusamy, Viswanathan, et al.. (2017). Neutralization of Pathogenic Fungi with Small‐Molecule Immunotherapeutics. Angewandte Chemie International Edition. 56(42). 13036–13040. 15 indexed citations

Micevic, Goran, Viswanathan Muthusamy, William Damsky, et al.. (2016). DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 Component RICTOR. Cell Reports. 14(9). 2180–2192. 60 indexed citations

Damsky, William, Goran Micevic, Katrina Meeth, et al.. (2015). mTORC1 Activation Blocks BrafV600E-Induced Growth Arrest but Is Insufficient for Melanoma Formation. Cancer Cell. 27(1). 41–56. 87 indexed citations

Muthusamy, Viswanathan, et al.. (2013). The Hematopoietic Stem Cell Regulatory Gene Latexin Has Tumor-Suppressive Properties in Malignant Melanoma. Journal of Investigative Dermatology. 133(7). 1827–1833. 27 indexed citations

10.

Singhal, Garima, Sebastian Szpakowski, Christina Ivins Zito, et al.. (2011). Phosphoproteomic Screen Identifies Potential Therapeutic Targets in Melanoma. Molecular Cancer Research. 9(6). 801–812. 73 indexed citations

11.

Frankel, Amylynne, Viswanathan Muthusamy, Wendy McKinnon, et al.. (2011). Familial multiple pilomatrixomas as a presentation of attenuated adenomatosis polyposis coli. Journal of Cutaneous Pathology. 39(4). 440–443. 23 indexed citations

12.

Held, Matthew A., David P. Curley, David Dankort, et al.. (2010). Characterization of Melanoma Cells Capable of Propagating Tumors from a Single Cell. Cancer Research. 70(1). 388–397. 73 indexed citations

13.

Muthusamy, Viswanathan, Marcus Bosenberg, & Narendra Wajapeyee. (2010). Redefining regulation of DNA methylation by RNA interference. Genomics. 96(4). 191–198. 10 indexed citations

14.

Carlson, Kacie R., et al.. (2010). A transient epidermolysis bullosa simplex‐like phenotype associated with bexarotene treatment in a G138E KRT5 heterozygote. Journal of Cutaneous Pathology. 37(11). 1155–1160. 3 indexed citations

15.

Smalley, Keiran S.M., Rooha Contractor, Thiennga K. Nguyen, et al.. (2008). Identification of a Novel Subgroup of Melanomas with KIT/Cyclin-Dependent Kinase-4 Overexpression. Cancer Research. 68(14). 5743–5752. 82 indexed citations

16.

Muthusamy, Viswanathan, Sekhar Duraisamy, C. Matthew Bradbury, et al.. (2006). Epigenetic Silencing of Novel Tumor Suppressors in Malignant Melanoma. Cancer Research. 66(23). 11187–11193. 137 indexed citations

17.

Muthusamy, Viswanathan, Cara Hobbs, Cristina Nogueira, et al.. (2006). Amplification of CDK4 and MDM2 in malignant melanoma. Genes Chromosomes and Cancer. 45(5). 447–454. 110 indexed citations

18.

Muthusamy, Viswanathan, et al.. (2006). Methylation of E-cadherin and hMLH1 genes in Indian sporadic breast carcinomas.. PubMed. 44(2). 115–9. 6 indexed citations

19.

Muthusamy, Viswanathan, et al.. (2003). Genomic instability and tumor-specific alterations in oral squamous cell carcinomas assessed by inter-(simple sequence repeat) PCR.. PubMed. 9(3). 1057–62. 15 indexed citations

20.

Muthusamy, Viswanathan, Nobuo Tsuchida, & G. Shanmugam. (2001). Selective deletion of p14(ARF) exon 1β of the INK4a locus in oral squamous cell carcinomas of Indians. Oral Oncology. 37(4). 341–344. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact